The chemical class designated as LOC730005 Inhibitors represents a group of compounds designed to selectively target the molecular entity LOC730005. The functional roles and cellular pathways associated with LOC730005 are currently under investigation, adding a layer of complexity to the understanding of this chemical class. Inhibitors within this category are carefully engineered molecules with the specific aim of modulating the activity or function of LOC730005, thereby inducing an inhibitory effect. The ongoing research into LOC730005 Inhibitors employs a multifaceted approach, integrating structural biology, medicinal chemistry, and computational methods to unravel the intricate details of the molecular interactions between the inhibitors and the target LOC730005.
Structurally, LOC730005 Inhibitors are crafted with distinct molecular features to enable selective binding to LOC730005. This selectivity is essential to minimize unintended effects on other cellular components, ensuring a targeted impact on the intended molecular target. The development of inhibitors within this chemical class necessitates a thorough exploration of structure-activity relationships, optimization of pharmacokinetic properties, and a comprehensive understanding of the molecular mechanisms underlying LOC730005 function. As researchers delve deeper into the functional aspects of LOC730005 Inhibitors, the knowledge generated contributes not only to deciphering the specific roles of LOC730005 but also to advancing our broader comprehension of cellular processes and molecular regulation. The exploration of LOC730005 Inhibitors represents a crucial avenue for expanding fundamental knowledge in molecular pharmacology and cellular biology.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $173.00 $418.00 | 43 | |
Doxorubicin intercalates DNA and disrupts topoisomerase-II-mediated DNA repair, potentially reducing transcription of genes such as LOC730005. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $32.00 $170.00 $385.00 | 63 | |
Etoposide inhibits topoisomerase II, leading to DNA breakage and potentially affecting transcription of various genes, including LOC730005. | ||||||
Rocaglamide | 84573-16-0 | sc-203241 sc-203241A sc-203241B sc-203241C sc-203241D | 100 µg 1 mg 5 mg 10 mg 25 mg | $270.00 $465.00 $1607.00 $2448.00 $5239.00 | 4 | |
Rocaglamide has been shown to inhibit translation initiation, which might decrease protein synthesis, potentially affecting LOC730005. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $36.00 $149.00 | 11 | |
5-Fluorouracil is incorporated into RNA, disrupting RNA processing and function, which can lead to decreased gene expression. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Bortezomib inhibits the proteasome, potentially affecting protein levels and turnover, which could influence LOC730005 expression. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
MG132 is a proteasome inhibitor that could stabilize transcriptional repressors, possibly leading to downregulation of certain genes. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $169.00 $299.00 | 66 | |
Tunicamycin inhibits N-linked glycosylation, stressing the ER and potentially downregulating protein expression, including LOC730005. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
Chloroquine raises endosomal pH, which can affect cell signaling and gene expression pathways, potentially reducing LOC730005 levels. | ||||||
Homoharringtonine | 26833-87-4 | sc-202652 sc-202652A sc-202652B | 1 mg 5 mg 10 mg | $51.00 $123.00 $178.00 | 11 | |
Homoharringtonine inhibits protein synthesis by preventing the initial elongation step of translation, which could decrease LOC730005 expression. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
EGCG has been suggested to affect various signaling pathways and could potentially influence gene expression, including LOC730005. | ||||||